RNA interference mediated inhibition of gene expression using short interfering nucleic acids (siNA)
US-12516321-B2 · Jan 6, 2026 · US
Cancilla Mark is listed as an inventor on 12 patents in our database. Major assignees and classification codes are summarized below.
| Metric | Value |
|---|---|
| Inventor | Cancilla Mark |
| Total patents | 12 |
| First publication | Feb 16, 2016 |
| Latest publication | Jan 6, 2026 |
Publications ranked by popularity score, then publication date.
US-12516321-B2 · Jan 6, 2026 · US
US-12068058-B2 · Aug 20, 2024 · US
US-11932854-B2 · Mar 19, 2024 · US
US-11854664-B2 · Dec 26, 2023 · US
US-2022195433-A1 · Jun 23, 2022 · US
US-11193126-B2 · Dec 7, 2021 · US
US-2021265024-A1 · Aug 26, 2021 · US
US-2021257046-A1 · Aug 19, 2021 · US
US-2018362977-A1 · Dec 20, 2018 · US
US-9970005-B2 · May 15, 2018 · US
Latest publications not already listed above.
Companies most often associated with this inventor's publications.
| Assignee | Patents |
|---|---|
| Sirna Therapeutics Inc | 8 |
| Merck Sharp & Dohme | 3 |
| Merck Sharp & Dohme Llc | 2 |
| Cancilla Mark | 1 |
| Cunningham James J | 1 |
Most common classification codes across this inventor's patents.
| CPC | Patents |
|---|---|
| C12N2310/321 | 8 |
| C12N2310/346 | 8 |
| C12N2320/51 | 8 |
| C12N2310/14 | 8 |
| C12N2320/32 | 8 |